Amylyx Pharmaceuticals annual gross margin
2022
2023
2024
Amylyx Pharmaceuticals Gross Margin Growth & History (AMLX)
Amylyx Pharmaceuticals's gross margin was 93.19% for fiscal 2024.
View full Amylyx Pharmaceuticals company overviewAmylyx Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 93.19% | −0.13 pp |
| 2023 | 2023-12-31 | 93.32% | +6.78 pp |
| 2022 | 2022-12-31 | 86.54% | — |
Amylyx Pharmaceuticals quarterly gross margin
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q3.24
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2024 | 2024-09-30 | 100.00% | +5.08 pp |
| Q1 2024 | 2024-03-31 | 93.29% | +0.69 pp |
| Q4 2023 | 2023-12-31 | 91.37% | — |
| Q3 2023 | 2023-09-30 | 94.92% | +44.77 pp |
| Q2 2023 | 2023-06-30 | 94.32% | — |
| Q1 2023 | 2023-03-31 | 92.60% | — |
| Q3 2022 | 2022-09-30 | 50.14% | — |
Amylyx Pharmaceuticals gross margin trends
Between the periods ended 2022-12-31 and 2024-12-31, Amylyx Pharmaceuticals's gross margin increased from 86.54% to 93.19%, a change of +6.65 percentage points. The latest reported quarter, Q3 2024, shows 100.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Amylyx Pharmaceuticals source filings ↗